You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Applied DNA Sciences previously partnered with Stony Brook University Hospital to validate the test, which received Emergency Use Authorization in May.
The company's Linea COVID-19 assay kit is a high-sensitivity real-time, reverse-transcriptase PCR-based assay to detect target sequences of the SARS-CoV-2 Spike gene.
As part of the deal, Applied DNA will permanently place robotic and diagnostic equipment at the hospital to enable validation of the test.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
LineaRx was formed last year to commercialize Applied DNA Sciences' technologies for DNA design, manufacture, and chemical modification by large scale PCR.
Though the effect of reference bias was inconsistent, the authors of a new study said it highlights the need for tools or approaches to minimize it.
Individuals with northern genetic ancestry were buried with more grave goods than individuals with local southern genetic ancestry, the researchers found.
In Cell this week: genome-wide chromatin accessibility profile of mouse tissues, urea cycle dysregulation in cancer, and more.
In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.
A Stony Brook University-led team re-analyzed the FOXP2 gene for signs of selection using a larger, more diverse cohort, but were unable to find any.
IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.
The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.
A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.
In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.